BASF’s 61-Euro Target: Wall Street Sees a Goldilocks Moment as Shareholders Weigh a Spin-Off

The Ludwigshafen-based chemical giant is approaching a pivotal juncture that could reshape both its portfolio and its share price. With the stock trading at 54.32 euros—just shy of its 52-week high of 54.70 euros—analysts at Citigroup have raised their price target to 61 euros, maintaining a “Buy” rating. The call is built on what analyst Sebastian Satz describes as a “Goldilocks scenario,” where supply-side distortions across chemical value chains are expected to bolster BASF’s pricing power and margins in a way the market has yet to fully price in.

The optimism isn’t confined to one bank. Bernstein Research has also set a 61-euro target, pointing to significant upside versus the current consensus. Both houses see the second quarter of 2026 as the inflection point for earnings growth, and Citigroup has placed the stock on its “positive Catalyst Watch” list. The bullish thesis is reinforced by the company’s ongoing share buyback program, which has accumulated more than 19.5 million shares since its launch in November 2025. A fresh tranche of roughly 124,000 shares was repurchased in mid-April alone, tightening the supply of stock and providing a floor under the price.

For income-focused investors, BASF offers a dividend yield of 4.2 percent—one of the highest in the DAX this season. The proposed payout of 2.25 euros per share for fiscal 2025 matches the previous year’s level, which itself was a painful cut from 3.40 euros in 2024. Crucially, management has committed to a floor of at least 2.25 euros annually through 2028, providing a measure of predictability for those building a retirement portfolio. The annual general meeting on April 30 in Mannheim is expected to approve the dividend proposal.

That same meeting carries a far more consequential item on the agenda: shareholders will vote on whether to spin off the Agricultural Solutions division into a standalone subsidiary. The move is widely seen as a precursor to a potential initial public offering in Frankfurt next year. If approved, it would mark the most significant structural change since the company’s post-war reorganization. The agricultural unit, which develops crop protection products and seeds, has been a steady performer but operates with different cyclical dynamics than BASF’s core chemicals business.

Should investors sell immediately? Or is it worth buying BASF?

The operational backdrop remains challenging. CEO Markus Kamieth has described 2026 as “another transition year,” with EBITDA before special items expected to land between 6.2 billion and 7.0 billion euros. The cost-cutting program, however, is running ahead of schedule: annual savings are on track to reach 2.3 billion euros by the end of next year. The new Verbund site in Zhanjiang, China—the company’s seventh such integrated facility and its largest single investment ever at roughly 8.7 billion euros—began operations in late March. The plant runs entirely on renewable electricity and is central to BASF’s strategy of expanding in Asia while decarbonizing its production base.

The stock has rallied more than 21 percent since the start of the year, reflecting growing confidence in the turnaround. A sustained break above the 54.70-euro resistance level could end the sideways trading pattern that has characterized recent months. The next hard data point comes on Thursday, April 30, when BASF releases detailed first-quarter results alongside the shareholder meeting. Analysts are forecasting full-year earnings of 2.54 euros per share, making a strong Q1 report essential to validate the elevated expectations and the 61-euro price target.

For private investors assembling a dividend-based retirement strategy, BASF occupies a distinct niche: high current yield with a guaranteed floor, exposure to the cyclical chemicals sector, and a potential catalyst from the agricultural spin-off. It is a bet on structural transformation—one that requires patience but offers a safety net in the form of that locked-in dividend. Whether the market’s newfound optimism proves justified will become clearer after April 30, when the numbers and the vote are both in.